Elite in Desmoid Tumor
Check Dr. Mrinal M. Gounder's experience treating your condition:
About Dr. Mrinal M. Gounder

Mrinal Gounder is an Oncologist in New York, New York. Gounder has been practicing medicine for over 19 years and is rated as an Elite expert by MediFind in the treatment of Desmoid Tumor. He is also highly rated in 33 other conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, Liposarcoma, and Liver Embolization. He is licensed to treat patients in New York and Illinois. Gounder is currently accepting new patients.

His clinical research consists of co-authoring 95 peer reviewed articles and participating in 15 clinical trials in the past 15 years. In particular, he has co-authored 9 articles and participated in 5 clinical trials in the study of Desmoid Tumor.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Mrinal M. Gounder it is best to call his office and ask if your insurance is accepted.

Accepts Medicare
1275 York Ave, New York, NY 10065
Background & Education
Graduate Institution
Other, 2004
Internal Medicine in IL
Hospital Affiliations
Memorial Sloan Kettering Cancer Center
Shore Medical Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

A Phase 1, First-in-human, Open-label, Dose Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-1287 to Patients With Advanced Solid Tumors
RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients With Progressing Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
A Phase 2 Study of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
A Phase 2 Study of Oraxol in Subjects With Cutaneous Angiosarcoma
A Phase III, Double Blind, Randomized, Placebo-Controlled Trial of Sorafenib in Desmoid Tumors or Aggressive Fibromatosis (DT/DF)
A Phase I, Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Subjects With Solid Tumors and Non-Hodgkin's Lymphoma
Phase 1 Trial of BC2059 (Tegavivint) in Patients With Unresectable Desmoid Tumor
A Phase I, Open-Label, Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
A Phase 2-3, Multicenter, Randomized, Double-blind Study of Selinexor (KPT-330) Versus Placebo in Patients With Advanced Unresectable Dedifferentiated Liposarcoma (DDLS)
Phase I Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores in Patients With Treatment-refractory Solid Tumor Malignancies
A Phase 1B/II Study of GDC-0449 (NSC 747691) in Combination With RO4929097, a Gamma-Secretase Inhibitor (GSI) in Advanced/Metastatic Sarcomas
View 11 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors